(Q57878020)

English

A new treatment principle for neuropathic pain? Approved oncologic drugs: Epidermal growth factor receptor (EGFR) inhibitors dramatically relieve severe neuropathic pain in a case series

No description defined

In more languages

edit

Statements

instance of

scholarly article

0 references

title

A new treatment principle for neuropathic pain? Approved oncologic drugs: Epidermal growth factor receptor (EGFR) inhibitors dramatically relieve severe neuropathic pain in a case series (English)

0 references

0 references

Harald Breivik

1

0 references

Audun Stubhaug

series ordinal

2

object named as

Audun Stubhaug

0 references

publication date

1 January 2013

0 references

published in

Scandinavian Journal of Pain

0 references

volume

4

0 references

issue

1

0 references

page(s)

1-2

0 references

cites work

Cetuximab alleviates neuropathic pain despite tumour progression

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.SJPAIN.2012.11.012

retrieved

21 January 2018

The neuropathic pain triad: neurons, immune cells and glia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.SJPAIN.2012.11.012

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.SJPAIN.2012.11.012

retrieved

21 January 2018

Identifiers

DOI

10.1016/J.SJPAIN.2012.11.012

0 references

PubMed publication ID

29913878

0 references

(Q57878020)

A new treatment principle for neuropathic pain? Approved oncologic drugs: Epidermal growth factor receptor (EGFR) inhibitors dramatically relieve severe neuropathic pain in a case series

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)